Figure 3.

Screening Cost Components (Totals and Proportions) from a Public Health System Payer Perspective. Panel A shows the component cost estimates for staff (dark blue), supplies, equipment, and facilities (light blue), laboratory processing (yellow), laboratory transport (orange) for both cervical cytology and HPV DNA testing in India, Kenya, Peru, South Africa, and Thailand. Panel B shows these same cost components as proportions of the total cost.